The Valley Desk

LetterJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerPublished

A Response to the Letter to the Editor: "Lazertinib Versus Osimertinib in EGFR-Mutant NSCLC: Efficacy, Toxicity, and Unaddressed Clinical Gaps"

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Letter
Venue
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published
PubMed ID
41519528
Added to directory
Source checked

Report a correction or request removal